Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
CSL Behring increases capacity in Bern.
Production of the vaccine candidate, developed by the University of Oxford and AstraZeneca, is underway in Australia.
CSL Behring scientists in Germany discovered that sodium laureth sulfate – found in many liquid soaps – works on various surf…
GM at CSL Behring’s Kankakee manufacturing facility looks back on an eventful first year.
Diversity is good for our people, it’s good for our business and it’s good for our patients.
New analysis confirms the threat of recurrent heart attacks still persists.
When leaders at CSL Behring set ambitious new targets, they were following in the footsteps of audaciously successful compani…
A potential hyperimmune treatment for COVID-19 reaches a U.S. regulatory milestone designed to test for effectiveness and saf…
Free COVID-19 antibody test, flu shot available for CSL Plasma donors.
Americas
Asia Pacific
Middle East
Europe